Compound Report Overview
Compound Name:
PD-131112
Compound Identifier:
703349
Mol Structure 2D:
703349
Molecular Weight:
403
Formula:
C19 H22 F N5 O4
Development Status:
Clinical, Phase I
SMILES:
CC(N)C(=O)NC1CCN(C1)c2nc3n(cc(C(=O)O)c(=O)c3cc2F)C4CC4